Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
BMC Cardiovascular Disorders|June 24, 2005
Peripheral arterial disease: a high risk - but neglected - disease populationJoseph Tomson, Gregory Y H LipBlood Pressure Monitoring|August 4, 2005
Blood pressure changes in acute haemorrhagic strokeJoseph Tomson, Gregory Y H LipCureus|October 19, 2022
Worsening Heart Failure and Atrial Flutter in a Patient Secondary to Cardiac Resynchronization Therapy Dyssynchrony: A Case ReportZahid Khan, George Besis, Joseph TomsonBMC Medicine|January 11, 2005
Blood pressure demographics: nature or nurture ... ... genes or environment?Joseph Tomson, Gregory Y H LipCureus|October 14, 2022
Tachycardia-Induced Cardiomyopathy in a Young Healthy Patient: A Case ReportZahid Khan, George Besis, Joseph TomsonHeart (British Cardiac Society)|September 29, 2006
Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillationGeorge I Varughese, Jeetesh V Patel, Joseph Tomson, et al.European Heart Journal|December 22, 2012
Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deathsJoseph Tomson, Jonathan Emberson, Michael Hill, et al.International Journal of Cardiology|June 20, 2006
Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarctionJeetesh V Patel, Kaeng W Lee, Joseph Tomson, et al.Maturitas|February 28, 2015
Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trialRobert Clarke, Connie Newman, Joseph Tomson, et al.Journal of the American Heart Association|October 26, 2017
Effects of Vitamin D on Blood Pressure, Arterial Stiffness, and Cardiac Function in Older People After 1 Year: BEST-D (Biochemical Efficacy and Safety Trial of Vitamin D)Joseph Tomson, Harold Hin, Jonathan Emberson, et al.Pageof 2